Table 1.
Extracts/Pure Compounds | HIV-1 RT-Associated RNase H IC50 (µg/mL) a |
HIV-1 Integrase LEDGF-Dependent IC50 (µg/mL) b |
---|---|---|
Punica granatum leaves extract (PGL) | 0.61 ± 0.02 | 0.12 ± 0.065 |
Punica granatum bark extract (PGB) | 0.22 ± 0.04 | 0.18 ± 0.02 |
Punica granatum peel extract (PGP) | 0.85 ± 0,01 | 0.5 ± 0.035 |
RDS1759 | 10.7 ± 0.9c | - |
Raltegravir | - | 0.058 ± 0.01 c |
a Extract concentration required to reduce the HIV-1 RT-associated RNase H activity by 50%. b Extract concentration required to inhibit the HIV-1 IN catalytic activity by 50% in the presence of LEDGF. c Compound concentration expressed in µM.